FirmdexStart free
Signet Therapeutics logo

Signet Therapeutics

Biotechnology Research in United States

Overview

Signet Therapeutics is a clinical-stage biotech company pioneering the development of first-in-class targeted cancer therapies using organoids and AI. Our lead program, SIGX1094, has entered Phase I clinical trials as a potential first-in-class targeted therapy for diffuse gastric cancer, a highly aggressive cancer with no approved targeted treatments. SIGX1094 has received FDA Orphan Drug Designation and Fast Track Designation. It is also the world's first drug candidate developed by organoid and AI.

In addition to advancing our own pipeline, our organoid platform is available for external collaborations, providing innovative preclinical drug discovery and development services to biotech and pharmaceutical partners.

Driven by a vision to address urgent unmet medical needs, we are committed to transforming cancer treatment through cutting-edge science. Our team of experts embraces rigorous research, fearless innovation, and a relentless pursuit of excellence to bring new hope to cancer patients worldwide.

Contact us: contact@signettx.com

Join us: hr@signettx.com

Tagline

Address Unmet Medical Needs Through Innovation.

EMPLOYEES

11-50 employees

FOUNDED

2020

HQ

Boston, Massachusetts

TYPE

Partnership

Location

Street
—
City
Boston
Region
Massachusetts
Postal code
—
Country
United States

Social media

Email patterns

See email patterns for Signet Therapeutics

Address formats, how often each is used and the mail provider.

Start for free

Trade fairs

See trade fairs for Signet Therapeutics

Fair names, cities and years.

Start for free

FAQ

What is the company name?

en.signettx.com is the website of Signet Therapeutics.

What is the industry of the company?

Signet Therapeutics (en.signettx.com) is in the Biotechnology Research industry.

When was the company founded?

Signet Therapeutics (en.signettx.com) was founded in 2020.

How many employees does the company have?

Signet Therapeutics (en.signettx.com) has 11-50 employees.

What is the company type?

The company type of Signet Therapeutics (en.signettx.com) is Partnership.

Where is the company headquartered?

Signet Therapeutics (en.signettx.com) is headquartered in Boston, Massachusetts.

What is the address of the company?

The address of Signet Therapeutics (en.signettx.com) is Boston, Massachusetts, United States.

What are the social media accounts of the company?

The social media account of Signet Therapeutics (en.signettx.com) is LinkedIn.

Similar companies